Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoantibodies in scleroderma.

N F Rothfield1

  • 1Department of Medicine, University of Connecticut School of Medicine, Farmington.

Rheumatic Diseases Clinics of North America
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Scleroderma patients have specific autoantibodies targeting DNA-binding proteins crucial for cell functions. These autoantibodies are linked to disease manifestations and prognosis, suggesting an antigen-driven immune response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis of lupus erythematosus and rheumatoid arthritis in children.

Pediatric clinics of North America·2015
Same author

A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.

Arthritis and rheumatism·1999
Same author

Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.

Arthritis and rheumatism·1998
Same author

Range of antinuclear antibodies in "healthy" individuals.

Arthritis and rheumatism·1997
Same author

A cross-reactive idiotype in scleroderma.

Clinical and experimental immunology·1997
Same author

CRI-EM is a human idiotype highly specific for scleroderma.

Annals of the New York Academy of Sciences·1997
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Scleroderma is characterized by the presence of autoantibodies.
  • Autoantigens in scleroderma are increasingly understood at a molecular level.

Purpose of the Study:

  • To discuss antinuclear and antinucleolar antibodies in scleroderma.
  • To examine the clinical significance and exclusiveness of these autoantibodies.

Main Methods:

  • Characterization of autoantigens.
  • cDNA cloning and epitope definition.
  • Review of immunoglobulin and IgG subclass data.

Main Results:

  • Many common autoantigens are DNA-binding proteins vital for transcription and cell division.

Related Experiment Videos

  • The prevalence and clinical significance of autoantibodies in relation to disease manifestations and prognosis are examined.
  • The unique exclusiveness of major autoantibodies is discussed.

    • Conclusions:

    • Autoantibodies in scleroderma patients likely result from an antigen-driven immune response.
    • Understanding these autoantibodies aids in assessing disease prognosis and manifestations.